Skip to main content
Tech.euFundingExplorerBeta

Healthtech funding in Q4 2022

European Healthtech startup funding raised during Q4 2022.

In Q4 2022, 174 European Healthtech companies closed 182 funding rounds and raised €1.7B in equity funding (excluding debt and grants), down 41.5% versus Q4 2021. Debt rounds added €243M. UK led by capital raised, and EIC Accelerator was the most active investor. Data as of 20 Nov 2026.

Equity funding
€1.7B
-41.5% vs Q4 2021 · excl. debt & grants · +€243M debt
Funding rounds
182
-1.1% vs Q4 2021
Companies
174
Top country
UK
Rank among sectors
#4
9.7% of sector funding
Debt financing
€243M
12.3% of total
Top-10 round share
37.3%
of disclosed capital
Rounds ≥ €100M
3

Funding by month

€ raised vs rounds, by month
Healthtech — funding by month, Q4 2022 — interactive chart.
Data table
FundingRounds
Oct€726M66
Nov€729M62
Dec€526M54

Top countries

by € raised
Healthtech — top countries by capital, Q4 2022 — interactive chart.
Data table
Healthtech — top countries by capital, Q4 2022
UK€540M
Germany€346M
Switzerland€305M
Denmark€192M
France€129M
Spain€110M
Belgium€95M
Netherlands€74M

Stage mix

by € raised
Healthtech — stage mix, Q4 2022 — interactive chart.
Data table
Healthtech — stage mix, Q4 2022
Other€789M
Series A€455M
Debt€243M
Series B€238M
Series C€135M
Seed€58M
Grant€32M
Pre-Seed€14M
Series D+€13M
Crowdfunding€3.0M

Exits & M&A

16 Acquisition · 1 IPO

17 exits · €2.9B disclosed.

ImmucorAcquisitionNov 2022€2.0B
Neogene TherapeuticsAcquisitionNov 2022€310M
CordisAcquisitionOct 2022€240M
Focus-X TherapeuticsAcquisitionNov 2022€237M
OculisIPOOct 2022€82M
BModestoAcquisitionNov 2022€75M

Top deals

largest disclosed rounds in Q4 2022
CompanyStageDateAmount
VectivbioOtherOct 2022€127M
TauRx PharmaceuticalsOtherNov 2022€115M
Demant ASDebtNov 2022€115M
Osler DiagnosticsSeries CNov 2022€85M
Resolve BiosciencesSeries BOct 2022€72M
CatalYmSeries CNov 2022€50M
MinervaXDebtDec 2022€50M
UnivercellsOtherOct 2022€44M
Novadip BiosciencesSeries BNov 2022€40M
NumaresOtherDec 2022€40M
Nucleome TherapeuticsSeries AOct 2022€38M
Opna BioSeries ANov 2022€37M
anokionOtherOct 2022€36M
Mablink BioscienceSeries AOct 2022€31M
AqemiaSeries AOct 2022€30M

Top investors

most active in Q4 2022, by deal count